162
Views
0
CrossRef citations to date
0
Altmetric
Letters to the editor: Original Scientific Contributions

Unexpected refractory hypotension following intradermal minoxidil injection

, , , &
Pages 319-320 | Received 26 Jan 2023, Accepted 08 Mar 2023, Published online: 29 Mar 2023

References

  • York K, Meah N, Bhoyrul B, et al. A review of the treatment of male pattern hair-loss. Expert Opin Pharmacother. 2020;21(5):603–612.
  • Abdallah MAER, Shareef R, Soltan MY. Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata. J Dermatolog Treat. 2022;33(2):1126–1129.
  • Uzel BPC, Takano GHS, Chartuni JCN, et al. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: a randomized, placebo-controlled trial. Dermatol Ther. 2021;34(1):e14622.
  • Sica DA. Minoxidil: an underused vasodilator for resistant or severe hypertension. J Clin Hypertens. 2004;6(5):283–287.
  • Adams MH, Poynor WJ, Garnett WR, et al. Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers. Biopharm Drug Dispos. 1998;19(8):501–515.
  • Fleishaker JC, Andreadis NA, Welshman IR, et al. The pharmacokinetics of 2.5‐ to 10‐mg oral doses of minoxidil in healthy volunteers. J Clin Pharmacol. 1989;29(2):162–167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.